3004

Zhejiang Garden Biopharmaceutical Co.,Ltd. Stock Price

SZSE:300401 Community·CN¥7.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300401 Share Price Performance

CN¥13.79
-1.26 (-8.37%)
CN¥13.79
-1.26 (-8.37%)
Price CN¥13.79

300401 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

1 Risk
4 Rewards

Zhejiang Garden Biopharmaceutical Co.,Ltd. Key Details

CN¥1.2b

Revenue

CN¥546.1m

Cost of Revenue

CN¥695.3m

Gross Profit

CN¥393.5m

Other Expenses

CN¥301.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.56
56.01%
24.31%
52.0%
View Full Analysis

About 300401

Founded
2000
Employees
1021
CEO
Huanzheng Ma
WebsiteView website
www.hybiotech.com

Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3. The company was formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd. and changed its name to Zhejiang Garden Biopharmaceutical Co.,Ltd. in April 2023. Zhejiang Garden Biopharmaceutical Co.,Ltd. was founded in 2000 and is based in Dongyang, China.

Recent 300401 News & Updates

Recent updates

No updates